The impact of known breast cancer polygenes on critical illness insurance
From MaRDI portal
Publication:4576777
DOI10.1080/03461238.2013.794520zbMath1398.91304OpenAlexW2120117434MaRDI QIDQ4576777
Catherine Donnelly, Angus S. Macdonald, Craig Adams
Publication date: 10 July 2018
Published in: Scandinavian Actuarial Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1080/03461238.2013.794520
adverse selectionbreast cancerBRCA1BRCA2family historycritical illnessgenetics and insurancepolygene
Lua error in Module:PublicationMSCList at line 37: attempt to index local 'msc_result' (a nil value).
Cites Work
- The genetics of breast and ovarian cancer IV: a model of breast cancer progression
- The genetics of breast and ovarian cancer V: application to income protection insurance
- The Genetics of Breast and Ovarian Cancer III: A new model of family history with insurance applications
- Adult Polycystic Kidney Disease and Critical Illness Insurance
- Pricing Term Insurance in the Presence of a Family History of Breast or Ovarian Cancer
- Unnamed Item
- Unnamed Item
This page was built for publication: The impact of known breast cancer polygenes on critical illness insurance
